Cargando…

Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China

The vaccine is still the best clinical measure for effective prevention and control of coronavirus disease 2019 (COVID-19). The vaccine-associated ocular adverse reactions should be noted in detail among the medical community. We reported twelve eyes of 9 patients presented at the Department of Opht...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Kunpeng, Pan, Lijie, Guo, Hui, Wu, Xinyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801805/
https://www.ncbi.nlm.nih.gov/pubmed/35111790
http://dx.doi.org/10.3389/fmed.2021.823346
_version_ 1784642545018470400
author Pang, Kunpeng
Pan, Lijie
Guo, Hui
Wu, Xinyi
author_facet Pang, Kunpeng
Pan, Lijie
Guo, Hui
Wu, Xinyi
author_sort Pang, Kunpeng
collection PubMed
description The vaccine is still the best clinical measure for effective prevention and control of coronavirus disease 2019 (COVID-19). The vaccine-associated ocular adverse reactions should be noted in detail among the medical community. We reported twelve eyes of 9 patients presented at the Department of Ophthalmology, Qilu Hospital of Shandong University from March to August 2021 with ocular complaints following COVID-19 vaccination. The main inclusion criterion was the development of ocular symptoms within 14 days after receiving a dose of an inactivated COVID-19 vaccine. The mean (SD) age was 44.7 ± 16.5 years (range, 19–78 years), among which seven (77.8%) cases were women. The mean time of ocular adverse events was 7.1 days (range, 1–14 days) after receiving the inactivated COVID-19 vaccine. One patient was diagnosed with choroiditis, 1 with uveitis, 4 with keratitis, 1 with scleritis, 1 with acute retinal necrosis, and 1 with iridocyclitis. Although the causal relationship between vaccines and ocular adverse events cannot be established from this case series report, physicians should pay attention to the ocular adverse reactions following the COVID-19 vaccine administration.
format Online
Article
Text
id pubmed-8801805
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88018052022-02-01 Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China Pang, Kunpeng Pan, Lijie Guo, Hui Wu, Xinyi Front Med (Lausanne) Medicine The vaccine is still the best clinical measure for effective prevention and control of coronavirus disease 2019 (COVID-19). The vaccine-associated ocular adverse reactions should be noted in detail among the medical community. We reported twelve eyes of 9 patients presented at the Department of Ophthalmology, Qilu Hospital of Shandong University from March to August 2021 with ocular complaints following COVID-19 vaccination. The main inclusion criterion was the development of ocular symptoms within 14 days after receiving a dose of an inactivated COVID-19 vaccine. The mean (SD) age was 44.7 ± 16.5 years (range, 19–78 years), among which seven (77.8%) cases were women. The mean time of ocular adverse events was 7.1 days (range, 1–14 days) after receiving the inactivated COVID-19 vaccine. One patient was diagnosed with choroiditis, 1 with uveitis, 4 with keratitis, 1 with scleritis, 1 with acute retinal necrosis, and 1 with iridocyclitis. Although the causal relationship between vaccines and ocular adverse events cannot be established from this case series report, physicians should pay attention to the ocular adverse reactions following the COVID-19 vaccine administration. Frontiers Media S.A. 2022-01-17 /pmc/articles/PMC8801805/ /pubmed/35111790 http://dx.doi.org/10.3389/fmed.2021.823346 Text en Copyright © 2022 Pang, Pan, Guo and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Pang, Kunpeng
Pan, Lijie
Guo, Hui
Wu, Xinyi
Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China
title Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China
title_full Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China
title_fullStr Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China
title_full_unstemmed Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China
title_short Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China
title_sort case report: associated ocular adverse reactions with inactivated covid-19 vaccine in china
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801805/
https://www.ncbi.nlm.nih.gov/pubmed/35111790
http://dx.doi.org/10.3389/fmed.2021.823346
work_keys_str_mv AT pangkunpeng casereportassociatedocularadversereactionswithinactivatedcovid19vaccineinchina
AT panlijie casereportassociatedocularadversereactionswithinactivatedcovid19vaccineinchina
AT guohui casereportassociatedocularadversereactionswithinactivatedcovid19vaccineinchina
AT wuxinyi casereportassociatedocularadversereactionswithinactivatedcovid19vaccineinchina